Convergent Effects of Resveratrol and PYK2 on Prostate Cells
Authors:
- Andrea ConteACAndrea Conte
- Annamaria KisslingerAKAnnamaria Kisslinger
- Claudio ProcacciniCPClaudio Procaccini
- Simona PaladinoSPSimona Paladino
- Olimpia OlivieroOOOlimpia Oliviero
- Francesca De AmicisFAFrancesca De Amicis
- Deriggio FaicchiaDFDeriggio Faicchia
- Dominga FasanoDFDominga Fasano
- Marilena CaputoMCMarilena Caputo
- Giuseppe MatareseGMGiuseppe Matarese
- Giovanna Maria PierantoniGPGiovanna Maria Pierantoni
- Donatella TramontanoDTDonatella Tramontano
Open Access
- 13 September 2016
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (9) , 1542
Abstract
Resveratrol, a dietary polyphenol, is under consideration as chemopreventive and chemotherapeutic agent for several diseases, including cancer. However, its mechanisms of action and its effects on non-tumor cells, fundamental to understand its real efficacy as chemopreventive agent, remain largely unknown. Proline-rich tyrosine kinase 2 (PYK2), a non-receptor tyrosine kinase acting as signaling mediator of different stimuli, behaves as tumor-suppressor in prostate. Since, PYK2 and RSV share several fields of interaction, including oxidative stress, we have investigated their functional relationship in human non-transformed prostate EPN cells and in their tumor-prone counterpart EPN-PKM, expressing a PYK2 dead-kinase mutant. We show that RSV has a strong biological activity in both cell lines, decreasing ROS production, inducing morphological changes and reversible growth arrest, and activating autophagy but not apoptosis. Interestingly, the PYK2 mutant increases basal ROS and autophagy levels, and modulates the intensity of RSV effects. In particular, the anti-oxidant effect of RSV is more potent in EPN than in EPN-PKM, whereas its anti-proliferative and pro-autophagic effects are more significant in EPN-PKM. Consistently, PYK2 depletion by RNAi replicates the effects of the PKM mutant. Taken together, our results reveal that PYK2 and RSV act on common cellular pathways and suggest that RSV effects on prostate cells may depend on mutational-state or expression levels of PYK2 that emerges as a possible mediator of RSV mechanisms of action. Moreover, the observation that resveratrol effects are reversible and not associated to apoptosis in tumor-prone EPN-PKM cells suggests caution for its use in humans.Keywords
Funding Information
- Regione Campania (POR Campania FSE 2007-2013)
This publication has 64 references indexed in Scilit:
- Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT CellsPLOS ONE, 2013
- Resveratrol Induces Long-Lasting IL-8 Expression and Peculiar EGFR Activation/Distribution in Human Keratinocytes: Mechanisms and Implications for Skin AdministrationPLOS ONE, 2013
- Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 PathwayPLOS ONE, 2012
- Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Suppression of Autophagy by FIP200 Deletion Impairs DNA Damage Repair and Increases Cell Death upon Treatments with Anticancer AgentsMolecular Cancer Research, 2011
- ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescenceThe FEBS Journal, 2009
- A Pyk2–Vav1 complex is recruited to β3-adhesion sites to initiate Rho activationBiochemical Journal, 2009
- Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibitionChemico-Biological Interactions, 2005
- Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell culturesExperimental & Molecular Medicine, 2000
- Suppression of Pyk2 Kinase and Cellular Activities by Fip200Journal of Cell Biology, 2000